Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

December 17, 2018 06:50 ET | Source: Interpace Diagnostics Group, Inc.

Interpace Announces Notice of Allowance from U.S. Patent and Trademark Office Covering BarreGEN®

BarreGEN® is Interpace’s Lead Molecular Diagnostic Pipeline Product for Barrett’s Esophagus Parsippany, NJ, Dec. 17, 2018 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (“Interpace”)...